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Abstract
Background: To accurately diagnose giardiosis in dogs, knowledge of diagnostic test characteristics and expected
prevalence are required. The aim of this work was to estimate test characteristics (sensitivity and specificity) of four
commonly used diagnostic tests for detection of Giardia duodenalis in dogs.
Methods: Fecal samples from 573 dogs originating from four populations (household dogs, shelter dogs, hunting
dogs and clinical dogs) were examined with centrifugation sedimentation flotation (CSF) coproscopical analysis,
direct immunofluorescence assay (DFA, Merifluor Cryptosporidium/Giardia®), a rapid enzyme
immunochromatographic assay (IDEXX SNAP Giardia®) and qPCR (SSU rDNA) for presence of G. duodenalis. Bayesian
latent class analysis was used to determine test performance characteristics and to estimate G. duodenalis
prevalence of each of the four dog populations.
Results: All tests were highly specific. IDEXX SNAP Giardia® showed the highest specificity (99.6%) and qPCR the lowest
(85.6%). The sensitivities were much more variable, with qPCR showing the highest (97.0%) and CSF the lowest (48.2%)
sensitivity. DFA was more sensitive than IDEXX SNAP Giardia®, but slightly less specific. Prevalences of G. duodenalis
differed substantially between populations, with the hunting dogs showing the highest G. duodenalis prevalence (64.9%)
and the household dogs the lowest (7.9%).
Conclusions: This study identifies qPCR as a valuable screening tool because of its high sensitivity, whereas methods
using microscopy for cyst identification or cyst wall detection should be used in situations where high specificity is
required. G. duodenalis is a prevalent gastro-intestinal parasite in Dutch dogs, especially in dogs living in groups (hunting
and shelter dogs) and clinical dogs.
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Background
Giardia spp. are among the most prevalent parasites in
dogs worldwide. The genus Giardia consists of six
species, of which Giardia duodenalis (syn. G. lamblia,
G. intestinalis) infects mammals such as humans, dogs,
cats and cattle [1]. Giardia duodenalis has been further
classified into eight assemblages (A to H), with various
degrees of host specificity [1]. Dogs can be infected with
G. duodenalis assemblages C and D and the potentially
zoonotic assemblages A and B [2]. Giardia infection often
is asymptomatic (giardiasis). If it becomes symptomatic
(giardiosis), diarrhea is the most common symptom.
Several diagnostic tests for the detection of G. duodenalis
are available. Detection of trophozoites and cysts with clas-
sic coproscopical methods and detection of coproantigens
(cyst wall proteins) with rapid point of care immunochro-
matographic assays are the most commonly used tests in
veterinary practice. Direct fluorescence assays have
largely replaced classic coproscopical detection of cysts
in veterinary research [3, 4]. More recently, molecular
techniques have been developed, such as a quantitative
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real time PCR (qPCR) with a reportedly high sensitivity
and specificity [5, 6].
Prevalences in dogs range between 0.4–34% in healthy
adult dogs, 2.3–25% in dogs with signs of gastro-intestinal
illness, 7–63% in puppies and 2.3–50% in dogs living in
groups [7–17]. Several diagnostic tests with different test
characteristics have been used to determine these preva-
lences [18]. To be able to compare these prevalences
properly, insight is needed in the test characteristics.
Using a large cohort of dogs within four populations,
the aim of this study was to compare test characteristics
(sensitivity and specificity) of four commonly used tests
for the detection of G. duodenalis in dogs. Additionally,
prevalences for each dog population were estimated. The
tests were a centrifugation sedimentation flotation (CSF)
coproscopical technique, a direct immunofluorescence
assay (DFA, Merifluor® Cryptosporidium/Giardia), a
rapid enzyme immunochromatographic assay (IDEXX
SNAP Giardia®) and a quantitative real time PCR (qPCR).
Appointing one test as the gold standard will overestimate
the characteristics of that test and as a consequence
underestimate the sensitivity and specificity of the other
tests. In order to obtain unbiased estimates of sensitivity
and specificity, a Bayesian latent class analysis was used
without assuming any test to be a perfect reference test.
Methods
Dogs
Fecal samples from in total 646 Dutch dogs belonging to
four populations were collected between October 2013
and December 2014. Of these, 573 were tested with all
four diagnostic tests. These 573 dogs are further subdi-
vided below.
The household dogs consisted of 210 privately owned
household dogs older than 6 months, participating in a
study on Toxocara canis [19]. The dog owners collected
the fecal samples and submitted them by mail.
The shelter dogs consisted of 137 shelter dogs from 16
shelter-kennels and the hunting dogs consisted of 34
dogs from two hunting-kennels. Fecal samples of the
shelter and hunting dogs were collected by instructed
personnel at the kennel or by veterinarians in training.
The fecal samples were taken to the laboratory by the
visiting veterinarians in training.
The clinical dogs consisted of 192 dogs for which a fecal
sample was submitted to the Veterinary Microbiological
Diagnostic Center (VMDC) of the Faculty of Veterinary
Medicine of Utrecht University, The Netherlands, for
endoparasite testing. Most fecal samples were sent in for
diagnosing a possible parasitic cause of clinical symptoms
and a few for control of therapy or for routine monitoring.
Fecal samples were processed as soon as possible after
arrival, ranging from the same day to 5 days after collec-
tion. Because the fecal samples of the household and
clinical dogs were sent in by mail, the interval between
collection and processing of the samples was longer for
the clinical and household dogs than for the shelter and
hunting dogs.
Centrifugation, sedimentation, flotation
Coproscopical analysis with CSF on fecal samples of
household and group-housed dogs was performed as de-
scribed previously [20]. In brief, 3–5 g of feces were sus-
pended in approximately 55 ml of water and, after sieving,
poured in a 12 ml centrifuge tube. Therefore, the contents
of the tube corresponded to 0.6–1.0 g of feces. After cen-
trifuging for 2 min at 1500× g, the supernatant was dec-
anted. A sucrose solution (1.27–1.30 g/cm3) was added to
the sediment, resuspended and centrifuged for 2 min at
1500× g with a coverslip on the meniscus. Then, the
coverslip with approximately 50 μl of suspension attached
to it, was removed upright and placed on a microscopic
slide. For logistic reasons, approximately a third of the
fecal samples of household and group-housed dogs were
pooled. Here for, 3–5 g of each of the two samples were
suspended in approximately 110 ml of water. When cysts
were detected, the samples were both retested separately.
The samples of the clinical dogs were examined in routine
diagnostics setting by the VMDC, using ZnSO4 solution
(1.34 g/cm3) instead of sucrose. The performance of both
protocols was similar (data not shown). Microscopic slides
were examined at 100× and 400× magnification. Cysts
were semi-quantitatively scored with the use of a five class
scoring system: -, none; +, a few in the whole slide; ++,
several in the whole slide; +++, many; or ++++, very many
in every field of view at 100× magnification.
The theoretical detection limit of the used CSF tech-
niques were 1–1.7 cysts per gram feces.
Direct immunofluorescence assay
One gram of feces was mixed well with 3 ml SAF
(sodium acetate acetic acid formalin) and stored in the
dark at room temperature until analysis. Cysts were de-
tected with DFA, using the Merifluor® Cryptosporidium/
Giardia kit (Meridian Bioscience Diagnostics Inc., Cin-
cinnati, Ohio, USA) as described previously [3], with
some minor modifications. In brief, the feces-SAF sus-
pension was strained through a sieve to remove large
debris. After centrifugation for 5 min at 1000× g, the
supernatant was discarded and the sediment, if neces-
sary, was filled up to 1 ml with distilled water and
stirred. An aliquot of 10 μl was placed on a treated DFA
slide with a 10 μl transfer loop. After staining, according
to the manufacturer’s protocol, the slide was examined
with a fluorescence microscope (Olympus, Tokyo, Japan;
type BHS-F) for specific apple-green bright colored
cysts, fitting size indication according to the manual
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of the test kit. The theoretical detection limit was 100
cysts per gram feces.
Rapid enzyme immunochromatographic assay
For this assay, feces (0.5–1.0 g) were stored at -20 °C
until analysis. The IDEXX SNAP Giardia® test (IDEXX
Laboratories Inc., Westbrook, Maine, USA) was per-
formed as described by the manufacturer after the feces
aliquot was thawed to room temperature.
Quantitative PCR
Feces (0.2 g) were stored at -20 °C until analysis. DNA
was extracted with the QIAamp Fast Stool Mini Kit
(Qiagen, Germantown, Maryland, USA) according to the
manufacturer’s instructions with the following modifica-
tions. The extraction buffer was added to the frozen
fecal sample after which the sample was thawed and sus-
pended. The sample was subsequently frozen for 15 min
at -80 °C. After thawing, the sample was heated for 5
min at 95 °C and the centrifugation step to obtain the
supernatant was performed after proteinase K lysis.
From the 100 μl eluted DNA, 5 μl was used for each
PCR reaction. A 63 bp fragment of the SSU rDNA gene
was amplified with qPCR [5]. Reactions were performed
on Light Cycler 480 (Roche, Penzberg, Germany), with
Phocine Herpes Virus as internal control. For the cali-
bration curve and to determine cysts per gram feces
(cpg), Giardia cysts from a CSF positive feces sample
were purified by centrifugation on a sucrose cushion
[21] and counted in a modified Fuchs-Rosenthal count-
ing chamber. DNA was isolated from the cysts suspen-
sion as described above and was 10-fold serial diluted.
The serial dilutions ranged from 3 × 106 to 3 cysts per
gram feces. Dilutions from 3 × 106 to 300 cysts per gram
feces always tested positive and yielded a linear relation
between Cp and log-cyst concentration. A calibration
curve was used from 3 × 106 cysts per gram feces
(= 2500 cysts per PCR reaction) with Cp values of
24.36–24.38 to 300 cysts per gram feces (0.25 cysts per
PCR reaction) with Cp values of 38.96–39.43. Therefore,
the cut-off Cp value was set on 40. Because a Giardia
cyst is 16N and there are approximately 60 copies of
rDNA in one genome, the theoretical detection limit of
the qPCR was 1.25 cysts per gram feces.
To further investigate the performance of the qPCR,
two additional experiments were conducted. First, all
available samples positive with qPCR and negative with
the other three diagnostic tests (n = 63) were amplified
with the same primers, reagents and conditions as used
for the qPCR, but run as a conventional PCR. Twenty
randomly selected samples negative for all diagnostic
tests, were run as negative control. Serial diluted purified
cysts from two dog isolates were also run this way. Puri-
fication on sucrose cushion and counting was done as
described above and after DNA isolation, the samples
were 5-fold serial diluted. Secondly, to confirm that G.
duodenalis was detected and not one of the other spe-
cies of Giardia, all 35 samples from the shelter and
hunting dogs which tested positive with the qPCR but
negative with the other three tests, were subjected to the
nested PCR on SSU rDNA [22]. The amplified products
were sequenced and aligned to reference sequences from
the GenBank database by Clustal W using the software
Lasergene 12 (DNASTAR®, Madison, USA). The primers
and probe of the qPCR [5] were also aligned this way.
Statistical analyses
To estimate the test characteristics of the diagnostic
tests (sensitivity and specificity) assuming that none of
the tests can be seen as a gold standard, a latent class
analysis was performed in a Bayesian context [23], sim-
ultaneously estimating the prevalence in each of the four
dog populations. The parameters prevalence and charac-
teristics of the tests were given uninformative priors.
Conditional covariance was modeled between DFA and
CSF, since they both rely on detecting cysts. Sensitivity
and specificity for each test and their 95% PPI (posterior
probability interval) were estimated. OpenBUGS, version
3.2.3 [24] was used for implementation of the model.
The Markov chain Monte Carlo (MCMC) algorithm was
run for 10,000 iterations and the first 1000 iterations
were discarded as 'burn-in'. Convergence was assessed
by running three MCMC chains in parallel and visually
inspecting the time-series plots. Autocorrelation was
assessed by inspecting the autocorrelation plots. The
analysis was repeated whilst excluding the four dog pop-
ulations, one at a time, to check for constant accuracy of
tests across populations.
Differences in proportions of positive test results and
the correlation between CPG and semi-quantitative de-
tection of cyst shedding by CSF were assessed using the
Chi-square, Fisher’s exact or two-sample Wilcoxon
rank-sum test, as appropriate.
The level of agreement between the four tests was
assessed using the kappa (ƙ) statistic. The ƙ outcome
represents a slight (ƙ < 0.2), fair (0.2 ≤ ƙ ≤ 0.4), moderate
(0.4 ≤ ƙ ≤ 0.6), substantial (0.6 ≤ ƙ ≤ 0.8) or almost perfect
(ƙ > 0.8) agreement [25]. Statistical analyses were performed
using STATA 13 (StataCorp LP, College Station, USA).
Results
Number of samples examined with each of the diagnostic
tests
Of the 646 samples, 639 were tested with the CSF
(59 positives), 645 were tested with the DFA (116
positives), 580 were tested with the IDEXX SNAP
Giardia® test (86 positives), and all 646 were tested
with the qPCR (189 positives). Overall, 573 samples
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were examined with all four tests. Data for all sam-
ples are provided in Additional file 1.
Comparison of diagnostic tests
Table 1 shows the test results for the 573 samples that
were tested with all four assays. In total, 420 samples
of 573 (73.3%) had the same test result for all four
diagnostic tests, either positive (n = 39; 6.8%) or negative
(n = 381; 66.5%). There were no samples that tested nega-
tive with qPCR and positive with all three other tests.
Table 2 shows the estimated sensitivities and specificities
of the four tests according to the Bayesian latent class ana-
lysis. The qPCR showed the highest sensitivity and the
CSF microscopy the lowest. DFA and IDEXX SNAP Giar-
dia® were moderately sensitive. IDEXX SNAP Giardia®,
however, was the most specific, closely followed by CSF
microscopy and the qPCR had the lowest specificity. DFA
was slightly less specific than IDEXX SNAP Giardia® and
CSF microscopy. The overall between the four tests
was 0.56 (95% CI: 0.52–0.61), which represents a moder-
ate to substantial agreement.
The estimated prevalences of G. duodenalis in the four
populations of dogs are presented in Table 3.
There was accordance between semi-quantitative de-
tection of cysts with CSF and positivity of IDEXX SNAP
Giardia®, DFA and especially qPCR. The higher the
number of cysts detected with CSF, the more unlikely the
other tests had a negative outcome. There was a signifi-
cant correlation between CPG (determined with qPCR)
and semi-quantitative cyst detection determined with CSF
(χ2 = 49.3, df = 3, P = 0.0001). CSF tested positive at a
higher median CPG (3.5 × 104, IQR 1.1 × 103–9.6 × 104),
compared to IDEXX SNAP Giardia® (2.5 × 104, IQR
8.9 × 103–6.9 × 104) and DFA (1.9 × 104, IQR 7.1 ×
103–5.8 × 104).
Specificity of qPCR
To gain more insight in the possible causes of the 70
uniquely qPCR positives (Table 1), we conducted two
confirmation experiments on 63 of those samples
(Additional file 2 and Additional file 3). Also, the
primers and probe of the qPCR were aligned to GenBank
Giardia sequences (Additional file 4) [26]. The
uniquely qPCR positive samples run under conventional
conditions (Additional file 2: Figure S1) resulted in ampli-
fication of the specific product in 86% of the samples,
while all negative samples also were negative in the con-
firmation experiment [27]. Additional file 2: Figure S2
shows the gels of the serial diluted purified cysts from
two dog isolates. The experiments and alignments
showed that the qPCR is able to amplify DNA of G.
duodenalis assemblages A to H and possibly G. psit-
taci. We found no indication that G. duodenalis as-
semblages E to H (false positive infection status) or G.
psittaci (false positive test result) were detected with
qPCR.
The median cpg of the 70 samples that were only posi-
tive with qPCR was 2.1 × 103 (IQR 1.1 × 103–6.5 × 103),
which was significantly lower (Wilcoxon rank-sum test,
Z = 7.404, P < 0.0001) than the median CPG of all other
Table 1 Cross-classified test results of four diagnostic tests for
the detection of G. duodenalis
CSF DFA SNAPa qPCR No. of samples
+ + + + 39
+ + + - 0
+ + - + 9
+ - + + 2
- + + + 30
- - + + 9
- - - + 70
- + - + 13
+ - - - 1
+ + - - 0
+ - + - 0
+ - - + 5
- - + - 2
- + - - 10
- + + - 2
- - - - 381
aSNAP = IDEXX SNAP Giardia®
Table 2 Estimated median sensitivities and specificities of the
four tests with Bayesian latent class analysis
Sensitivity (%) Specificity (%)
Median 95% PPIa Median 95% PPI
CSF 48.2 38.4–58.4 99.5 98.4–99.9
DFA 78.6 67.9–87.3 96.9 94.7–98.3
SNAPb 71.9 60.9–81.9 99.6 98.5–99.9
qPCR 97.0 92.1–99.5 85.6 81.7–89.3
aPPI = posterior probability interval
bSNAP = IDEXX SNAP Giardia®
Table 3 Prevalences of Giardia duodenalis in four dog populations,
estimated by Bayesian latent class analysis
Dog population Median (%) 95% PPIa
Household 7.9 4.4–12.5
Shelter 21.0 14.4–29.3
Hunting 64.9 43.5–86.2
Clinical 24.7 18.8–31.3
aPPI = posterior probability interval
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qPCR positive samples (n = 119) being 1.8 × 104
(IQR 6.6 × 103–4.8 × 104). Corresponding mean Cp
values were 35.5 versus 32.1, respectively.
Giardia cyst shedding based on qPCR results
There was a significant difference in the number of cysts
shed (cpg) by dogs of different populations (χ2 = 21.8,
df = 3, P = 0.0001). The qPCR positive clinical dogs
(n = 64) showed the highest shedding of cysts (median
cpg 2.5 × 104, IQR 3.6 × 103–8.5 × 104) and the qPCR
positive shelter dogs (n = 48) the lowest (median cpg
3.1 × 103, IQR 1.1 × 103–1.2 × 104). The qPCR positive
hunting dogs (n = 30) and household dogs (n = 47)
showed intermediate shedding of cysts (median cpg
1.2 × 104, IQR 6.4 × 103–2.2 × 104 and median cpg
5.4 × 103, IQR 1.5 × 103–1.3 × 104, respectively).
Discussion
Bayesian approaches have been used for comparison of
commonly used diagnostic tests for G. duodenalis in
dogs before, but the relatively recently developed qPCR
has not yet been included [3, 28]. To calculate test
performances in absence of both a gold standard and a
priori information on infection status of the dogs, we
performed a Bayesian latent class analysis, using the
cross classified test results of CSF, DFA, IDEXX SNAP
Giardia® and qPCR.
Three assumptions are made when using a Bayesian
latent class model [23]. The first assumption is condi-
tional independence given disease status. Since CSF and
DFA both detect cysts, conditional independence seems
unlikely, so conditional covariance for these two tests
was included in the model. As the other two tests both
use different approaches for identifying G. duodenalis
presence, conditional independence can be assumed for
these tests. Secondly, the model assumes constant sensi-
tivity and specificity across the four populations. To evalu-
ate this assumption, we ran the model, whilst excluding
each dog population one by one. Specificity and sensitivity
estimates were stable during this analysis, except for sensi-
tivity of IDEXX SNAP Giardia®, which decreased to 60.0%
when the clinical dogs were excluded (results not shown).
This may suggest that the sensitivity of IDEXX SNAP
Giardia® is higher in clinical dogs compared to the other
populations. Indeed, we found the number of cysts per
gram feces to be higher in clinical dogs, but why this did
not affect the three other tests cannot be fully explained
with our data. Finally, the model assumes differences in
prevalence between populations, which is true for our data
since the prevalence ranged from 7.9% in household dogs
to 64.9% in hunting dogs.
Latent class models estimate the sensitivity and speci-
ficity based on test-outcome data from animals of un-
known disease status. Thus, disease status is a latent
variable which is defined by the combination of all tests
used in the model. In our study, the four tests all rely on
direct detection of Giardia, but do so in different ways.
The qPCR is positive when Giardia DNA (SSU rDNA)
is detected. IDEXX SNAP Giardia® is positive when sol-
uble Giardia specific cyst wall antigen GSA-65 [29] is
detected, and CSF and DFA when intact cysts are de-
tected. In case of a positive test result, it does not auto-
matically mean that the dog is infected with G.
duodenalis. Because of the host specificity of Giardia,
only ingestion of cysts of the appropriate Giardia species
and assemblage can result in a patent gastro-intestinal
infection. This means that ingestion of cysts of G. duo-
denalis assemblage A, B, C or D can lead to true infec-
tions in dogs. Ingestion of cysts of non-canid Giardia
species, such as G. muris, G. microti or G. psittaci, or G.
duodenalis assemblages E, F, G or H, will not lead to a
patent infection in dogs and as a result, it is very unlikely
that intact cysts will be present in the feces. Therefore,
positive results with CSF and DFA generally represent
true infection. However, it is possible to mistake other
structures for Giardia cysts, which may lead to CSF and
DFA false positive results. Given the lower specificity,
this appears to occur more often with the DFA. Positive
results of IDEXX SNAP Giardia® nearly always represent
infection rather than mere passage, since this test had
the highest specificity. The qPCR was originally devel-
oped for detection of G. duodenalis in human feces. The
test characteristics of qPCR have been evaluated for hu-
man diagnostics, although not with latent class analysis
[30]. For veterinary use, it is important to know which
Giardia species and assemblage can be amplified. The
dog, by its behavior, easily encounters all kinds of Giar-
dia cysts. For coprophagy alone, it is estimated that at
least half of the household dogs exhibit this behavior
[20], let alone dogs that hunt, eat soil or drink from
water puddles. So, dogs have a relatively high chance of
picking up Giardia of any species and assemblage com-
pared to environmental exposure of humans in devel-
oped countries. In our study, seventy out of the total of
573 samples (12.2%) tested positive with qPCR and
negative in the three other tests. Based on the model es-
timates for the overall true prevalence (20.0%) and speci-
ficity of qPCR (85.6%), the expected total number of
false positives in our samples was 66. Therefore, on aver-
age, 35% of all qPCR positive results (n = 189) might
have been false positive. When assuming all false posi-
tives tested negative in the other three tests, 94% of the
70 uniquely qPCR positives may have tested false positive.
To gain more insight whether the relatively low specificity
of the qPCR was caused by false positive test results or
represents false negative infection status and consequently
an underestimation of the true prevalence, two additional
experiments were conducted. Also, primers and probe of
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the qPCR were aligned with Giardia sequences available
on GenBank. The results show that detection with the
qPCR of non-canid assemblages E, F, G and H and of G.
psittaci is possible. Literature shows that dogs are mostly
infected with G. duodenalis C and D, followed by A and B
[10, 31]. Indeed, the 12 samples of hunting and shelter
dogs in additional Experiment 2 that could be sequenced,
were all G. duodenalis assemblage D. It is therefore con-
cluded that the low specificity of the qPCR in dogs is likely
at least partially caused by the relatively low sensitivities of
the other three tests used in the latent class analysis to
identify the latent true disease status.
With the latent class analysis, qPCR had by far the
highest sensitivity (97.0%), CSF the lowest (48.2%) and
DFA (78.6%) and IDEXX SNAP Giardia® (71.9%) had
intermediate sensitivity. The differences in median CPG
at which the CSF, DFA and IDEXX SNAP Giardia®
tested positive, were in accordance with these results.
The results were also in accordance with the theoretical
detection limits of qPCR (1.25 cysts per gram feces) and
DFA (100 cysts per gram feces), but not with that of
CSF (1–1.7 cysts per gram feces). The theoretical detec-
tion limit of CSF was vastly overestimated as our results
show that CSF tested positive at a higher median CPG
than DFA. It can therefore be assumed that the detection
limits of CSF are in reality higher than the detection limit
of the DFA. Detection limits for the IDEXX SNAP
Giardia® test, which detects cyst wall proteins, could
not be estimated in advance. From our results, it is likely
that the theoretical detection limit of the IDEXX SNAP
Giardia® is fairly similar to the detection limit of the DFA.
The qPCR detects DNA of cysts, intact or not, and
trophozoites, which is, after DNA isolation, equally dis-
tributed throughout the tested sample. In the DNA iso-
lation procedure, the DNA present in 0.2 gram of feces
was eventually eluted in 100 μl. In combination with the
DNA amplification steps this concentration step results
in qPCR being the most sensitive diagnostic tests, al-
though only a very small amount of the fecal sample is
tested. As mentioned before, CSF and DFA depend on
the detection of intact Giardia cysts. Although the cysts
are notoriously robust, especially in water, in fecal sam-
ples they show a tendency to deteriorate relatively
quickly [32]. Temperature and duration of storage of the
fecal sample will therefore affect the actual detection
limit and sensitivities of both CSF and DFA more than
of enzyme immunochromatographic assay and qPCR.
Also, Giardia cysts are sensitive to dehydration and
might not be homogeneously distributed throughout the
fecal sample. Since cyst shedding is not consistent [33],
this further affects the sensitivity of tests relying on cyst
detection. In this study, we processed fecal samples as
soon as possible after arrival and to optimize storage
conditions for DFA, SAF was added to the fecal sample in
accordance to the manufacturer’s manual. Although per-
forming the CSF and adding SAF (DFA) to the fecal sam-
ple was done as quickly as possible after collecting the
sample, it could not be avoided that for some samples
(especially the household and clinical dogs) this took more
than a few days. By affecting the sensitivity of CSF and
DFA, this could also have had a negative effect on
the estimated prevalences of the household and clinical
dogs. The sensitivity of qPCR could also have been
affected, because fecal components are known to
affect DNA in deteriorated cysts. However, consider-
ing the results of the model, when excluding each
dog population one by one, the negative effects of the
time it took before the samples were processed ap-
peared not to be substantial.
The low sensitivity of the CSF microscopy on single
day samples found in this study is in accordance with
other studies [18, 28]. Performing the CSF on three-day
samples, which is commonly advised for G. duodenalis
diagnostics, would increase the sensitivity of CSF mi-
croscopy without a marked reduction in specificity
using a parallel interpretation of the repeated testing
[25]. Since microscopy is the most widely available
test that provides information about a patent G. duo-
denalis infection in combination with additional infor-
mation about the presence of other gastrointestinal
parasites, this test remains very useful for both diag-
nostic and research purposes. It should be noted that
the specificity of CSF microscopy for detection of G.
duodenalis is high, provided it is performed by expe-
rienced examiners.
Commercially available point of care assays are fast,
user-friendly and require little experience. They are
therefore widely used in veterinary practice. With our
latent class analysis, IDEXX SNAP Giardia® was shown
to be highly specific (99.6%) but lacking sensitivity
(71.9%). IDEXX SNAP Giardia® is registered for use in
dogs and cats. This coproantigen test detects G. duode-
nalis assemblages C, D and F. According to literature,
assemblages A and B are very likely detected as well
[34, 35]. Compared to IDEXX SNAP Giardia®, DFA
had a higher sensitivity (78.6%), which is in accord-
ance with another Bayesian study [3].
Finally, for all tests, whether it concerns the highly
sensitive qPCR or the least sensitive CSF, clinicians
need to thoroughly consider the possible causes of a
positive test together with the test characteristics to
avoid over-diagnosing and over-treatment of Giardia. In
case of a positive test result for G. duodenalis the dog has
either giardiosis (infected and showing relevant symptoms
such as diarrhea), giardiasis (infected but no symptoms) or
is not truly infected. In the latter case, the test may
be positive due to passage or contamination. In case
of giardiosis, it can be expected that there generally
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will be high numbers of cysts in the feces. In such
cases it is likely that the qPCR will become positive
after fewer cycles (at lower Cp values). This is sup-
ported by the results showing that the higher the
number of cysts detected with the CSF, the more un-
likely it became that the other tests, including qPCR,
were negative. Also, the samples uniquely positive for
qPCR overall showed very low CPG levels.
Conclusions
Giardia duodenalis is a prevalent gastrointestinal para-
site in dogs, especially in hunting dogs. The qPCR is by
far the most sensitive test for detection of G. duodenalis
and therefore a useful tool for screening, although speci-
ficity of the qPCR was relatively low. Sensitivities of
IDEXX SNAP Giardia® and DFA were lower than of
qPCR, but because of their higher specificity and be-
cause of other test characteristics, such as information
about true infection status and user friendliness, these
tests are of value. CSF is the least sensitive test but re-
mains valuable because it is the only test which provides
information about other gastrointestinal parasites. It is
also highly specific and provides information about true
infection status.
Additional files
Additional file 1: Raw data. (XLSX 39 kb)
Additional file 2: Text. Experiment 1: Confirming true positivity of
samples only positive with the qPCR. Figure S1. SSU rDNA qPCR [5]
performed as conventional PCR without probe. Figure S2. Serial dilution
of template for SSU rDNA qPCR [5] performed as conventional PCR
without probe. (DOCX 1781 kb)
Additional file 3: Text. Experiment 2: Confirming detection of Giardia
duodenalis with the qPCR. (DOCX 36 kb)
Additional file 4: Text. Detection of Giardia duodenalis assemblages
and other Giardia species with the qPCR. (DOCX 363 kb)
Acknowledgements
The authors thank IDEXX Laboratories for financing the IDEXX SNAP Giardia®
tests and Meridian Bioscience Diagnostic Inc. for partly financing the
Merifluor Cryptosporidium/Giardia test kits. IDEXX Laboratories and Meridian
Bioscience did not have any influence on the design or outcome of this
study. The Veterinary Microbiological Diagnostic Center of the Faculty of
Veterinary Medicine of Utrecht University, the Shelter Medicine program at
the Department of Clinical Sciences of Companion Animals of the Faculty of
Veterinary Medicine of Utrecht University and the veterinarians in training
performing their research internship are acknowledged for their substantial
contributions and input. The owners of the dogs and staff of the kennels are
acknowledged for their cooperation.
Availability of data and materials
The datasets used and/or analyzed during the present study are presented
in the article and its additional files or are available from the corresponding
author upon reasonable request.
Authors’ contributions
MU, RN, FK, JW, LMG and HP conceived and designed the study. MU, RN and
FK were involved in collection and processing of the samples and conducted
most of the experiments. MU, RN, FK and HP trained and supervised the
veterinarians in training. FK optimized the DNA isolation protocol. JW and HP
were project leaders and made conceptual contributions. LMG performed the
statistical analysis and GK the Bayesian latent class analysis. MU wrote the
manuscript. All authors provided relevant input at different stages of
manuscript preparation. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Department of Infectious Diseases and Immunology, Faculty of Veterinary
Medicine, Utrecht University, Utrecht, The Netherlands. 2Present address:
National Institute for Public Health and the Environment (RIVM), Center for
Infectious Disease Control (CIb), Bilthoven, The Netherlands. 3Wageningen
Bioveterinary Research, Lelystad, The Netherlands. 4National Institute for
Public Health and the Environment (RIVM), Center for Infectious Disease
Control (CIb), Bilthoven, The Netherlands. 5Department of Farm Animal
Health, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The
Netherlands.
Received: 22 March 2018 Accepted: 13 July 2018
References
1. Plutzer J, Ongerth J, Karanis P. Giardia taxonomy, phylogeny and epidemiology:
Facts and open questions. Int J Hyg Environ Health. 2010;213:321–33.
2. Ryan U, Cacciò SM. Zoonotic potential of Giardia. Int J Parasitol. 2013;43:
943–56.
3. Geurden T, Berkvens D, Casaert S, Vercruysse J, Claerebout EA. Bayesian
evaluation of three diagnostic assays for the detection of Giardia duodenalis
in symptomatic and asymptomatic dogs. Vet Parasitol. 2008;157:14–20.
4. Rishniw M, Liotta J, Bellosa M, Bowman D, Simpson KW. Comparison of 4
Giardia diagnostic tests in diagnosis of naturally acquired canine chronic
subclinical giardiasis. J Vet Intern Med. 2010;24:293–7.
5. Verweij JJ, Schinkel J, Laeijendecker D, Van Rooyen MAA, Van Lieshout L,
Polderman AM. Real-time PCR for the detection of Giardia lamblia. Mol Cell
Probes. 2003;17:223–5.
6. Verweij JJ, Blangé RA, Templeton K, Schinkel J, Brienen EAT, van Rooyen
MAA, et al. Simultaneous detection of Entamoeba histolytica, Giardia lamblia,
and Cryptosporidium parvum in fecal samples by using multiplex real-time
PCR. J Clin Microbiol. 2004;42:1220–3.
7. Claerebout E, Casaert S, Dalemans AC, De Wilde N, Levecke B, Vercruysse J,
et al. Giardia and other intestinal parasites in different dog populations in
Northern Belgium. Vet Parasitol. 2009;161:41–6.
8. Becker AC, Rohen M, Epe C, Schnieder T. Prevalence of endoparasites in
stray and fostered dogs and cats in northern Germany. Parasitol Res. 2012;
111:849–57.
9. Epe C, Rehkter G, Schnieder T, Lorentzen L, Kreienbrock L. Giardia in
symptomatic dogs and cats in Europe - results of a European study. Vet
Parasitol. 2010;173:32–8.
10. Ballweber LR, Xiao L, Bowman DD, Kahn G, Cama VA. Giardiasis in dogs and
cats: update on epidemiology and public health significance. Trends
Parasitol. 2010;26:180–9.
11. Dupont S, Butaye P, Claerebout E, Theuns S, Duchateau L, Van de Maele I,
et al. Enteropathogens in pups from pet shops and breeding facilities. J
Small Anim Pract. 2013;54:475–80.
12. Carlin EP, Bowman DD, Scarlett JM, Garrett J, Lorentzen L. Prevalence of
Giardia in symptomatic dogs and cats throughout the United States as
determined by the IDEXX SNAP Giardia test. Vet Ther. 2006;7:199–206.
13. Overgaauw PAM, van Zutphen L, Hoek D, Yaya FO, Roelfsema J, Pinelli E, et
al. Zoonotic parasites in fecal samples and fur from dogs and cats in The
Netherlands. Vet Parasitol. 2009;163:115–22.
Uiterwijk et al. Parasites & Vectors  (2018) 11:439 Page 7 of 8
14. Tangtrongsup S, Scorza V. Update on the diagnosis and management of
Giardia spp. infections in dogs and cats. Top Companion Anim Med.
2010;25:155–62.
15. Upjohn M, Cobb C, Monger J, Geurden T, Claerebout E, Fox M. Prevalence,
molecular typing and risk factor analysis for Giardia duodenalis infections in
dogs in a central London rescue shelter. Vet Parasitol. 2010;172:341–6.
16. Mircean V, Györke A, Cozma V. Prevalence and risk factors of Giardia
duodenalis in dogs from Romania. Vet Parasitol. 2012;184:325–9.
17. Solarczyk P, Majewska AC. A survey of the prevalence and genotypes of
Giardia duodenalis infecting household and sheltered dogs. Parasitol Res.
2010;106:1015–9.
18. Bouzid M, Halai K, Jeffreys D, Hunter PR. The prevalence of Giardia infection
in dogs and cats, a systematic review and meta-analysis of prevalence
studies from stool samples. Vet Parasitol. 2015;207:181–202.
19. Nijsse R, Ploeger HW, Wagenaar JA, Mughini-Gras L. Toxocara canis in
household dogs: prevalence, risk factors and owners’ attitude towards
deworming. Parasitol Res. 2015;114:561–9.
20. Nijsse R, Mughini-Gras L, Wagenaar JA, Ploeger HW. Coprophagy in dogs
interferes in the diagnosis of parasitic infections by faecal examination. Vet
Parasitol. 2014;204:304–9.
21. Eysker M, Kooyman FNJ. Notes on necropsy and herbage processing techniques
for gastrointestinal nematodes of ruminants. Vet Parasitol. 1993;46:205–13.
22. Cacciò SM, Beck R, Almeida A, Bajer A, Pozio E. Identification of Giardia
species and Giardia duodenalis assemblages by sequence analysis of the 5.8S
rDNA gene and internal transcribed spacers. Parasitology. 2010;137:919–25.
23. Toft N, Jørgensen E, Højsgaard S. Diagnosing diagnostic tests: evaluating
the assumptions underlying the estimation of sensitivity and specificity in
the absence of a gold standard. Prev Vet Med. 2005;68:19–33.
24. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution,
critique and future directions. Stat Med. 2009;28:3049–67.
25. Dohoo I, Martin W, Stryhn H. Veterinary Epidemiologic Research. 2nd ed.
Charlottetown, PE, Canada: VER Inc.; 2009.
26. Feng Y, Xiao L. Zoonotic potential and molecular epidemiology of Giardia
species and giardiasis. Clin Microbiol Rev. 2011;24:110–40.
27. Boadi S, Polley SD, Kilburn S, Mills GA, Chiodini PL. A critical assessment of
two real-time PCR assays targeting the (SSU) rRNA and gdh genes for the
molecular identification of Giardia intestinalis in a clinical laboratory. J Clin
Pathol. 2014;67:811–6.
28. Uehlinger FD, Naqvi SA, Greenwood SJ, McClure JT, Conboy G, O'Handley R,
et al. Comparison of five diagnostic tests for Giardia duodenalis in fecal
samples from young dogs. Vet Parasitol. 2017;244:91–6.
29. Rosoff JD, Sanders CA, Sonnad SS, De Lay PR, Hadley WK, Vincenzi FF, et al.
Stool diagnosis of giardiasis using a commercially available enzyme
immunoassay to detect Giardia-specific antigen 65 (GSA 65). J Clin
Microbiol. 1989;27:1997–2002.
30. Soares R, Tasca T. Giardiasis: an update review on sensitivity and specificity
of methods for laboratorial diagnosis. J Microbiol Methods. 2016;129:98–102.
31. Heyworth MF. Giardia duodenalis genetic assemblages and hosts. Parasite.
2016;23:13.
32. Olson ME, Goh J, Phillips M, Guselle N, McAllister TA. Giardia cyst and
Cryptosporidium oocyst survival in water, soil, and cattle feces. J Environ
Qual. 1999;28:1991.
33. Dryden MW, Payne PA, Smith V. Accurate diagnosis of Giardia spp. and
proper fecal examination procedures. Vet Ther. 2006;7:4–14.
34. Piekarska J, Bajzert J, Gorczykowski M, Kantyka M, Podkowik M. Molecular
identification of Giardia duodenalis isolates from domestic dogs and cats in
Wroclaw, Poland. Ann Agric Environ Med. 2016;23:410–5.
35. Papini R, Carreras G, Marangi M, Mancianti F, Giangaspero A. Use of a
commercial enzyme-linked immunosorbent assay for rapid detection of
Giardia duodenalis in dog stools in the environment: a Bayesian evaluation.
J Vet Diagn Invest. 2013;25:418–22.
Uiterwijk et al. Parasites & Vectors  (2018) 11:439 Page 8 of 8
